Plain-English translation of NCT07224256 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The VOICE Study is testing a new device called the Neuralink N1 Implant, which is a small wireless brain implant connected to tiny electrode threads. This implant is designed to help people who have lost the ability to speak or move their arms due to conditions like stroke, spinal cord injury, or ALS. By reading signals from the brain, the implant aims to let people communicate again, even when their body cannot move.
Many people with severe paralysis or neurological conditions lose their ability to speak and cannot use their hands or arms to type or gesture. This new treatment offers hope for restoring communication and independence to patients who have limited options today.
You likely qualify if…
You likely don't qualify if…
If you are selected, you will undergo surgery to have the N1 Implant placed in your brain using a robotic system called the R1 Robot. The implant sits under your skull and connects wirelessly to an external device you can wear. After implantation, you will work with the research team to learn how to use the device to communicate, and you will attend follow-up visits to monitor your safety and progress.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States
Sponsor
Neuralink Corp
Enrollment target
~6 participants
Started
October 2025
Primary completion
October 2028
Age range
22 Years – 75 Years
Last updated on clinicaltrials.gov in November 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Neuralink Clinical Team
University of Texas Southwestern Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.